Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Qihan Biotech’s QN-019a Receives Clinical Clearance for Gene-Edited iPSC-Derived Cell Therapy in China

August 15, 2025
CompanyDeals

Major Pharma Companies Pledge Support for 250,000 Genomes Sequencing Project

December 1, 2024
CompanyDeals

Sumitomo Pharma to Invest $30 Million in China for New Product Development

December 1, 2024
CompanyDrug

Antengene Initiates Phase I ERASER Study for ATG-017 in Combination with Nivolumab

December 1, 2024
CompanyDrug

Sichuan Huiyu Pharmaceutical’s KRAS G12C Drug HYP-2090PTSA Accepted for NMPA Review

December 1, 2024
CompanyDeals

Puncture Robotic Secures $13.9 Million in Series A+ Funding to Advance Medical Robotics

December 1, 2024
CompanyDrug

Sanofi and AstraZeneca Receive FDA Approval for RSV Prevention Treatment Beyfortus

December 1, 2024
DrugPolicy / Regulatory

NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation

December 1, 2024
CompanyDeals

Cutia Therapeutics’ CU-40101 Completes Phase I Clinical Trial for Androgenetic Alopecia

December 1, 2024
CompanyDrug

Mabwell Bioscience’s 7MW3711 ADC for B7-H3 Gets Clinical Trial Approval in China

December 1, 2024
CompanyDrug

Bayer’s Kerendia Officially Launched in China for Type 2 Diabetes-Related CKD

December 1, 2024
CompanyDeals

Sensview Secures Tens of Millions in Series A+ Funding for X-Ray Detector Tech

December 1, 2024
1 2 … 9 10 11 12 13 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up